X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1038) 1038
Publication (112) 112
Book Chapter (16) 16
Book Review (12) 12
Book / eBook (2) 2
Conference Proceeding (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (788) 788
clinical neurology (489) 489
oncology (488) 488
index medicus (484) 484
male (457) 457
female (437) 437
adult (415) 415
middle aged (391) 391
anaplastic oligodendroglioma (333) 333
gliomas (332) 332
brain neoplasms - pathology (307) 307
chemotherapy (302) 302
brain neoplasms - genetics (286) 286
oligodendroglioma (273) 273
prognosis (272) 272
aged (271) 271
tumors (229) 229
medicine & public health (228) 228
anaplastic astrocytoma (225) 225
glioma (222) 222
survival (220) 220
glioblastoma (219) 219
radiotherapy (210) 210
temozolomide (203) 203
anaplastic oligodendrogliomas (190) 190
pathology (184) 184
brain neoplasms - drug therapy (179) 179
neurosciences (179) 179
surgery (179) 179
oligodendroglioma - genetics (172) 172
glioblastoma-multiforme (167) 167
cancer (162) 162
adolescent (160) 160
phase-iii trial (159) 159
brain neoplasms - therapy (155) 155
radiation-therapy (154) 154
brain neoplasms - mortality (146) 146
brain neoplasms - diagnosis (145) 145
oligodendroglioma - pathology (143) 143
neurology (133) 133
astrocytoma (132) 132
glioma - pathology (129) 129
treatment outcome (125) 125
brain tumors (118) 118
chromosomes, human, pair 1 - genetics (118) 118
retrospective studies (118) 118
magnetic resonance imaging (117) 117
brain-tumors (113) 113
survival analysis (113) 113
young adult (113) 113
glioma - genetics (112) 112
glioma - drug therapy (104) 104
malignant glioma (104) 104
dacarbazine - analogs & derivatives (101) 101
care and treatment (100) 100
combined modality therapy (100) 100
mutation (100) 100
astrocytoma - pathology (98) 98
19q (97) 97
child (96) 96
chromosome deletion (96) 96
diagnosis (94) 94
analysis (92) 92
phase-ii trial (92) 92
antineoplastic combined chemotherapy protocols - therapeutic use (90) 90
chromosomes, human, pair 19 - genetics (89) 89
immunohistochemistry (87) 87
oligodendroglioma - drug therapy (84) 84
brain neoplasms - surgery (82) 82
central-nervous-system (82) 82
disease-free survival (82) 82
survival rate (80) 80
anaplastic glioma (78) 78
oligodendroglioma - diagnosis (77) 77
brain cancer (74) 74
classification (74) 74
astrocytoma - genetics (73) 73
brain neoplasms - radiotherapy (72) 72
isocitrate dehydrogenase - genetics (72) 72
procarbazine (72) 72
antineoplastic agents - therapeutic use (71) 71
comparative genomic hybridization (71) 71
follow-up studies (71) 71
research (71) 71
malignant gliomas (70) 70
neurosurgery (69) 69
dacarbazine - therapeutic use (68) 68
glioma - therapy (68) 68
prognostic-factors (66) 66
glioma - diagnosis (65) 65
oligodendroglioma - mortality (65) 65
brain neoplasms - metabolism (64) 64
oligodendroglioma - therapy (63) 63
aged, 80 and over (62) 62
oligodendroglial tumors (62) 62
european organization (61) 61
glioblastoma multiforme (61) 61
glioma - mortality (60) 60
lomustine (60) 60
disease progression (59) 59
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1001) 1001
French (18) 18
German (10) 10
Japanese (9) 9
Czech (6) 6
Spanish (4) 4
Korean (3) 3
Hungarian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2006, Volume 42, Issue 15, pp. 2499 - 2503
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 3/2009, Volume 92, Issue 1, pp. 57 - 63
Journal Article
Journal of the Pakistan Medical Association, ISSN 0030-9982, 01/2019, Volume 69, Issue 1, pp. 132 - 134
Oligodendrogliomas are common intra-axial primary brain tumours, and carry special significance due to several key features, which when present provide better... 
Oligodendrogliomachemotherapy | Glioma | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | ANAPLASTIC OLIGODENDROGLIOMA | MUTATION | 19Q | RADIOTHERAPY | chemotherapy | PROCARBAZINE | Oligodendroglioma | Chemotherapy | Gene mutations | Patient outcomes | Drug metabolism | Development and progression | Genetic aspects | Drug therapy | Health aspects | Cancer
Journal Article
Journal Article
REVISTA DE NEUROLOGIA, ISSN 0210-0010, 10/2018, Volume 67, Issue 8, pp. 293 - 297
Introduction. Radiotherapy with procarbazine, lomustine, and vincristine (PCV) improves overall survival in patients with anaplastic oligodendroglioma 1p19q... 
PCV | LOMUSTINE | 1p19q codeletion | TUMORS | CHEMOTHERAPY | CLINICAL NEUROLOGY | Oligodendroglioma | PHASE-III TRIAL | ADJUVANT PROCARBAZINE | ANAPLASTIC OLIGODENDROGLIOMA | LOW-GRADE GLIOMA | VINCRISTINE | Temozolomide | EUROPEAN-ORGANIZATION | INTERGROUP
Journal Article
Journal Article
American Journal of Neuroradiology, ISSN 0195-6108, 10/2005, Volume 26, Issue 9, pp. 2410 - 2414
Journal Article
Journal Article
Journal Article
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, ISSN 1210-7859, 2014, Volume 77, Issue 4, pp. 428 - 434
Oligodendrogliomas are uncommon but extensively investigated tumours in neurooncology. Their superior sensitivity to radiotherapy and chemotherapy compared to... 
SURGERY | TREATMENT RECOMMENDATIONS | GLIOBLASTOMA-MULTIFORME | biomarkers | EUROPEAN ORGANIZATION | VINCRISTINE CHEMOTHERAPY | anaplastic oligodendroglioma | NEUROSCIENCES | personalized medicine | RADIATION-THERAPY | TEMOZOLOMIDE | PHASE-III TRIAL | ADJUVANT PROCARBAZINE | CODON 132 MUTATION | chromosome deletion | BRAIN
Journal Article